10-86892153-TAGA-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PM4_Supporting
The ENST00000372037.8(BMPR1A):βc.264_266delβ(p.Glu88del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,310 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ). Synonymous variant affecting the same amino acid position (i.e. I86I) has been classified as Likely benign.
Frequency
Consequence
ENST00000372037.8 inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMPR1A | NM_004329.3 | c.264_266del | p.Glu88del | inframe_deletion | 5/13 | ENST00000372037.8 | NP_004320.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMPR1A | ENST00000372037.8 | c.264_266del | p.Glu88del | inframe_deletion | 5/13 | 1 | NM_004329.3 | ENSP00000361107 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251380Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135864
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461310Hom.: 0 AF XY: 0.00000413 AC XY: 3AN XY: 727032
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.264_266delAGA variant (also known as p.E88del) is located in coding exon 3 of the BMPR1A gene. This variant results from an in-frame AGA deletion at nucleotide positions 264 to 266. This results in the in-frame deletion of a glutamate residue at codon 88. This alteration has been identified in a large family satisfying Amsterdam I criteria for HNPCC/Lynch syndome and segregated well with colorectal carcinomas and polyps in this family; however, none of the 264_266delAGA carriers presented with typical BMPR1A-associated juvenile polyposis (Nieminen TT et al. Gastroenterology 2011 Jul; 141(1):e23-6). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Juvenile polyposis syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This variant, c.264_266del, results in the deletion of 1 amino acid(s) of the BMPR1A protein (p.Glu88del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs771235294, gnomAD 0.0009%). This variant has been observed in individual(s) with colorectal cancer (PMID: 21640116). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 231317). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at